Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOMEPROMAZINE vs LEVOMILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOMEPROMAZINE vs LEVOMILNACIPRAN: Safety Overview

Metric LEVOMEPROMAZINE LEVOMILNACIPRAN
Total FAERS Reports 3,024 1,378
Deaths Reported 585 382
Death Rate 19.3% 27.7%
Hospitalizations 1,564 378
Average Patient Age 44.1 yrs 46.4 yrs
% Female Patients 47.2% 80.2%
FDA Approval Date Approved Prior to Jan 1, 1982 Feb 4, 2019
Manufacturer N/A Allergan, Inc.
Route N/A ORAL
Marketing Status Discontinued Prescription